ESTRO meets Asia 2024 - Abstract Book

S105

Interdisciplinary – CNS

ESTRO meets Asia 2024

4. Yang I, Sughrue ME, Rutkowski MJ, Kaur R, Ivan ME, Aranda D, et al. Craniopharyngioma: a comparison of tumor control with various treatment strategies. Neurosurg Focus. 2010;28(4):E5. 5. Schoenfeld A, Pekmezci M, Barnes MJ, Tihan T, Gupta N, Lamborn KR, et al. The superiority of conservative resection and adjuvant radiation for craniopharyngiomas. J Neurooncol. 2012;108(1):133-9. 6. Clark AJ, Cage TA, Aranda D, Parsa AT, Auguste KI, Gupta N. Treatment-related morbidity and the management of pediatric craniopharyngioma: a systematic review. J Neurosurg Pediatr. 2012;10(4):293 301. 7. Lin LL, Naqa IE, Leonard JR, Park TS, Hollander AS, Michalski JM, et al. Long-term outcome in children treated for craniopharyngioma with and without radiotherapy. Journal of Neurosurgery: Pediatrics PED.2008;1(2):126-30 8. Kilday JP, Caldarelli M, Massimi L, Chen RH, Lee YY, Liang ML, et al. Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN.Neuro Oncol. 2017;19(10):1398-407 9. U.S. Department of Health and Human Services. Common terminology criteria for adverse events (CTCAE) [Internet]. Cancer.gov; 2017 [cited 2023 Jan 30] 10. Jose CC, Rajan B, Ashley S, Marsh H, Brada M. Radiotherapy for the treatment of recurrent craniopharyngioma. Clin Oncol (R Coll Radiol) [Internet]. 1992;4(5):287–9. 12. Zhou Z, Zhang S, Hu F. Endocrine Disorder in Patients With Craniopharyngioma. Front Neurol [Internet]. 2021;12. 13. Müller HL. Craniopharyngioma. Endocr Rev [Internet]. 2014;35(3):513–43. 14. Hamblin R, Vardon A, Akpalu J, Tampourlou M, Spiliotis I, Sbardella E, et al. Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance. Lancet Diabetes Endocrinol [Internet]. 2022;10(8):581–8. 15. Lo AC, Howard AF, Nichol A, Sidhu K, Abdulsatar F, Hasan H, et al. Long-term outcomes and complications in patients with craniopharyngioma: The British Columbia cancer agency experience. Int J Radiat Oncol Biol Phys [Internet]. 2014;88(5):1011–8. 16. Daughters K, Unwin K, Rees DA. The psychological impact of adult-onset craniopharyngioma: A qualitative study of the experience of patients and clinicians. Eur J Oncol Nurs [Internet]. 2023;65(102346):102346. 17. Dogra P, Bedatsova L, Van Gompel JJ, Giannini C, Donegan DM, Erickson D. Long-term outcomes in patients with adult-onset craniopharyngioma. Endocrine [Internet]. 2022;78(1):123–34. 18. Nuijts MA, Veldhuis N, Stegeman I, van Santen HM, Porro GL, Imhof SM, et al. Visual functions in children with craniopharyngioma at diagnosis: A systematic review. PLoS One [Internet]. 2020 [cited 2024 Feb 6];15(10):e0240016. 19. Piloni M, Gagliardi F, Bailo M, Losa M, Boari N, Spina A, Mortini P. Craniopharyngioma in Pediatrics and Adults. Adv Exp Med Biol. 2023;1405:299-329. 11. Kalapurakal J, Goldman S, Hsieh Y, Tomita T, Marymont M. Clinical outcome in children with recurrent craniopharyngioma after primary surgery. Cancer J [Internet]. 2000

121

Digital Poster

Pediatric patients with CNS tumor receiving radiotherapy at Prof. Ngoerah Hospital in 2021-2023.

Ngakan P.D. Ganapati, Dwi P Hastuti